Pond Technologies

What Pond Technologies does

Pond Technologies Holdings Inc. is a Canadian public cleantech company (TSXV: POND) headquartered in Markham, Ontario, that has developed a proprietary photobioreactor platform for cultivating microalgae using industrial CO2 emissions. The closed-system bioreactors use patented CO2 management, proprietary LED lighting, and sensor-driven automation (with an explicit AI integration initiative launched in 2025) to convert industrial exhaust gases into algae biomass at claimed growth rates 20-50x faster than alternative technologies and 1000x less land than soy or corn. The company monetizes this platform through three primary streams: (1) technology licensing and royalties to industrial emitters and partners (notably Livalta/AB Agri at ~CAD$5.5M for an animal-feed deployment in the UK); (2) sale of high-value algae-derived products (Spirulina, Astaxanthin, Phycocyanin) under the Regenurex consumer brand and through the Pond Naturals distribution subsidiary; and (3) carbon capture and utilization services that generate carbon credits for industrial customers.

The company operates through wholly-owned subsidiaries Pond Naturals (distribution of natural ingredients), Pond Biotech (genetically modified algae expressing proteins for diagnostics and therapeutics), and the Regenurex consumer brand. Customer segments include large industrial CO2 emitters (oil and gas, cement, power, mining), animal feed producers, and nutraceutical/food companies; named enterprise customers include Livalta/AB Agri, a Fortune 500 Canadian oilsands producer, CSV Midstream Solutions, and British Sugar.

Since founding (~2009) and IPO on TSXV in 2018, the company has accumulated 26+ patents globally but has remained in early commercialization with repeated small dilutive financings. In March 2025, management engaged Gray Strategic Partners for a strategic review, which culminated in October 2025 with a proposed reverse takeover of Find Familiar Spirits (terminated April 2026) and an April 2026 LOI to option the Zoo Bay Uranium Project from UraniumX Discovery Corp., which would convert the listed entity into a Tier 2 mining issuer with substantive board and management restructuring.

Name

Pond Technologies

Legal name

Pond Technologies Holdings Inc.

Website

https://pondtech.com

Company type

Public

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Pond Technologies develops proprietary photobioreactor systems that convert industrial CO2 emissions into algae biomass, licensing the technology to industrial emitters and selling algae-derived nutraceuticals, animal feed, and specialty ingredients through its Pond Naturals subsidiary and Regenurex consumer brand.

Ownership category

akta.pro rank

Product category

Algae Biotechnology

NAICS

Aquaculture (1125), Other Aquaculture (112519)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Seaweed & Algae Aquaculture (incl. microalgae) (AFAEAAAE)

akta.pro secondary industry

Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF)

Keywords

• Carbon capture technology
• Algae cultivation systems
• Industrial emissions reduction
• Photobioreactor systems
• Algae biomass production

Headquarters

HQ city

Markham

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Technology Licensing: Pond licenses its algae-growing technology to third parties for upfront technology access fees and ongoing royalties based on production from commercial plants deployed.
2. Algae Product Sales: Sale of algae-derived products including organic Spirulina, Astaxanthin, phycocyanin, and nutraceutical supplements under the Regenurex brand. Also bulk algae biomass for animal feed, food, and industrial applications.
3. Carbon Abatement Services: Carbon capture and utilization services for industrial emitters. The company captures CO2 emissions and converts them to algae biomass, with emitters receiving carbon credits.
4. Demonstration System Sales: Sale of algae demonstration systems to partners for pilot projects. Example: CAD$2.9 million system sold to Livalta for UK installation.
5. Biotech Research Services: Scale-up and technology access agreements for specialized applications such as growing antigens in algae for diagnostic testing, with milestone payments.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Pond Technologies develops and licenses proprietary photobioreactor systems that capture industrial CO2 emissions and convert them into valuable algae biomass using AI-driven control, patented CO2 management, and proprietary LED lighting. The company generates revenue through technology licensing (fees and royalties), algae-derived product sales (Spirulina, Chlorella, Astaxanthin, Phycocyanin) for nutraceutical, animal feed, and industrial markets, and carbon abatement services for industrial emitters.

Product overview

Pond Technologies operates a platform-plus-products business model centered on its proprietary algae-growing photobioreactor technology. The core platform converts industrial CO2 emissions into valuable algae biomass through automated, sensor-driven bioreactors. The company generates revenue through multiple channels: (1) licensing its technology to third parties for fees and royalties, (2) operating its Pond Naturals distribution subsidiary for bulk natural ingredients, and (3) selling branded consumer products under Regenurex including Organic Spirulina and Astaxanthin supplements. Additional divisions include Pond Biotech (genetically modified algae for pharmaceuticals) and algae-based animal feed partnerships with Livalta. Products span nutraceuticals, animal feed, industrial applications, and biotechnology.

Differentiator

Problem solved

Functional benefit

Brands

• Pond Naturals: Engaged in the production, formulation and creation of custom blended nutrition products. Operates as distribution channel for algae and natural ingredients.
• Pond Biotech
• Regenurex

Products and services

• Pond Photobioreactor / CO2 Abatement Platform Scalable proprietary bioreactor system that cultivates microalgae using industrial CO2 emissions. Uses LED lights, sensors, AI automation, and patented CO2 management to grow algae in controlled environments, enabling carbon capture and utilization at industrial sites.
• Organic Spirulina Blue-green algae superfood produced by Pond's closed bioreactor system containing 60-70% protein, phycocyanin, chlorophyll, B vitamins, and omega-6 fatty acids. Marketed as vegan, gluten-free, and GMO-free for food, nutraceutical, and supplement applications.
• Chlorella Unicellular green alga containing 55-67% protein, chlorophyll, dietary fiber, lutein, and minerals. Used in nutraceuticals and health supplements with documented antitumor, antioxidant, and immune-enhancing properties.
• Astaxanthin Natural antioxidant extracted from Haematococcus pluvialis algae at 3-5% content. Used in nutraceuticals and supplements, as aquaculture feed additive for salmon/shrimp coloration, and as natural preservative. Valued at $150,000+ per tonne in nutraceutical market.
• Phycocyanin (Blue Spirulina) Natural blue food colorant extracted from Spirulina, used in the food industry (including blue M&Ms), cosmetics, medicine, and genetics as a fluorescent tracer. FDA approved, with market prices of $175,000-$300,000 per tonne.
• Algae-Based Animal Feed High-protein algae feedstock for aquaculture and livestock containing up to 70% protein, omega fatty acids, and antioxidants. Superior amino acid profile compared to corn/soy. Commercialized via partnership with Livalta (AB Agri).

Quantifiable outcome

• 2:1 CO2 to algae ratio - 10 tonnes of CO2 removed yields 5,000 tonnes of algae
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

Partnerships

Eight partnerships are on record, tiered core, minor and flagship.

• UraniumX Discovery CorpcoreStrategic or Co-development Partner · 27 April 2026Non-binding LOI granting Pond exclusive option to acquire 100% interest in Zoo Bay Uranium Project in Saskatchewan's Athabasca Basin. Pond to issue 16M shares, pay $350,000 cash, and incur $4.5M in exploration expenditures over three years. Transaction would constitute change of business to mining issuer.
• Find Familiar SpiritsminorStrategic or Co-development Partner · 28 October 2025Proposed reverse takeover transaction (terminated April 2026) that would have resulted in fan-focused spirits company going public via Pond listing.
• Malone GroupcoreImplementation/ SI/ Consulting Partner · 1 November 2021Non-exclusive collaboration to pursue projects internationally. Malone Group promotes and recommends Pond to potential ESG clients and provides process and safety engineering expertise.
• Livalta (AB Agri)flagshipStrategic or Co-development Partner · 8 September 2021Exclusive global partnership to grow algae-based animal feed from CO2 emissions. Agreement includes supply agreement for algae demonstration system (CAD$2.9M) and license agreement with up to CAD$2.6M in technology access fees plus ongoing royalties. World's first scalable algae plant utilizing carbon emissions to produce protein for animal feed.
• Major Canadian Oilsands ProducercoreStrategic or Co-development Partner · 10 August 2021Scale-up and technology access agreement to grow COVID-19 antigens expressed from unique algae strain for rapid diagnostic testing. Up to CAD$1M in milestone payments including $150,000 on signing.
• CSV Midstream Solutions CorpcoreStrategic or Co-development Partner · 1 January 2021Partnership for carbon capture using Pond's algae technology at midstream facilities.
• British SugarcoreStrategic or Co-development Partner · 1 January 2021Host site for Livalta's pilot algae plant at Wissington site in Norfolk, UK. Site will demonstrate algae growth from CO2 emissions.
• Natural Resources Canada (NRC)coreStrategic or Co-development PartnerCommercial partner of Canadian National Research Council's Algae Carbon Conversion project designed to reduce CO2 emissions from Canadian oil sands operations.

Scale indicators8 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• AlgaEnergy: AlgaEnergy is a Spain-based microalgae biotechnology company producing Spirulina, Astaxanthin and other algae-derived ingredients for food, feed and agriculture, overlapping directly with Pond's algae cultivation platform and downstream product portfolio.
• Cyanotech Corporation: Cyanotech is a Hawaii-based producer of microalgae-derived nutraceuticals including Spirulina and Astaxanthin from Haematococcus pluvialis, directly competing with Pond's Regenurex and Pond Naturals product lines in the same ingredient categories and customer channels.

Broad incumbents

• Climeworks: Climeworks is a leading direct air carbon capture company; it competes indirectly for corporate carbon credit budgets and ESG mandates that Pond pitches to industrial emitters, though its technology (DAC vs. point-source bioreactor) is distinct.
• Corbion: Corbion is a large global ingredient supplier with an Algae Ingredients business producing algae-based omega-3 (DHA) and specialty ingredients, making it a broader incumbent competitor to Pond's high-value algae ingredient and feed protein positioning.
• Viridos (formerly Synthetic Genomics): Viridos is an algae biotechnology company developing genetically engineered algae for fuels and products, making it a credible incumbent comparable to Pond's biotech division and its algae strain engineering capabilities.
• Carbon Engineering (now Oxy-CFT): Carbon Engineering is a well-capitalized point-source and direct air CO2 capture developer acquired by Oxy Low Carbon Ventures; it competes for the same industrial emitter decarbonization capital that Pond's algae-based capture platform is designed to address.
• LanzaTech: LanzaTech is a commercial-stage carbon capture and utilization company that converts industrial CO2 and waste gases into fuels and chemicals using microbial fermentation, competing for the same industrial emitter customers and decarbonization budgets that Pond targets with its algae platform.

Regional players

• A4F (Algae for Future): A4F is a Portugal-based algae technology company engineering photobioreactor systems and producing algae biomass for feed and fuel; it overlaps with Pond's core photobioreactor IP but is primarily focused on European projects.

Others

• AB Agri (Livalta parent): AB Agri is the global agribusiness division of Associated British Foods and parent of Pond's flagship licensing partner Livalta; included as an ecosystem/partner comparable relevant to Pond's animal-feed go-to-market.

Emerging players

• Lumen Biosciences: Lumen Biosciences is a US biotech producing complex proteins using spirulina, overlapping with Pond Biotech's positioning around genetically modified algae expressing therapeutics and diagnostic antigens.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat5 records

Key risks1 record

Key highlights6 records

Customer concentration

• Xx.com/pondtechglobal
• YouTubeyoutube.com/channel/UCwr8lEh2Z6eshZDolixH7Ng
• Facebookfacebook.com/pondtechglobal
• LinkedInlinkedin.com/company/pondtechglobal
• Instagraminstagram.com/pondtechglobal

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries5 records

Funding overview

Funding rounds10 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pond Technologies